Ken Griffin Olink Holding Ab (Publ) Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$21.81 - $25.14 $148,308 - $170,952	-6,800 Reduced 15.85%	36,100 $848,000
Q4 2023 Feb 14, 2024	BUY	$14.29 - $25.95 $577,316 - $1.05 Million	40,400 Added 1616.0%	42,900 $1.08 Million
Q3 2023 Nov 14, 2023	BUY	$14.45 - $20.34 $8,670 - $12,204	600 Added 31.58%	2,500 $36,000
Q2 2023 Aug 14, 2023	SELL	$17.13 - $23.74 $66,807 - $92,586	-3,900 Reduced 67.24%	1,900 $35,000
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $42,548 - $53,042	-2,200 Reduced 27.5%	5,800 $130,000

Q4 2022 Feb 14, 2023	SELL	$12.64 - $25.52 $115,024 - $232,232	-9,100 Reduced 53.22%	8,000 $203,000
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $66,770 - $101,310	5,500 Added 47.41%	17,100 $208,000

38.1M

52.2K

134K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.